Batu Biologics

Batu Biologics is a preclinical biopharmaceutical company focused on developing and commercializing allogeneic cells in the field of immune modulation. Our products center on the concept of creating or breaking immune tolerance. The company is currently in the preclinical stage of drug development, with its two flagship products: Immstem and Vallovax. Batu Biologics has filed two provisional patents in the field of cancer immunotherapy and plans to significantly expand its intellectual property portfolio.